Skip to main content

Table 1 Baseline clinical features of patients at ICU admission

From: Validation of circulating histone detection by mass spectrometry for early diagnosis, prognosis, and management of critically ill septic patients

Participant characteristics

Control

N = 9

Sepsis

N = 11

Septic Shock

N = 69

P value

Age (years)

median (IQR)

68 (30)

53 (26)

67 (16)

n.s

Male sex

n (%)

4 (40)

8 (60)

41 (67)

n.s

APACHE II score

median (IQR)

11 (17)

17 (8)

22 (10)

 < 0.001b

SOFA score first day

median (IQR)

3 (4)

4 (5)

10 (5)

 < 0.001b

Charlson Index > 3

n (%)

0

3 (25)

27 (39)

n.s

Antibiotic 2 weeks prior to admission

n (%)

0

1 (8)

8 (12)

n.s

Hospital admission in the previous 3 months

n (%)

0

0

17 (25)

0.048c

Infection source

    

Abdominal

n (%)

1 (9)

23 (33)

n.s 

Respiratory

n (%)

7 (64)

21 (30)

 n.s

CNS

n (%)

1 (9)

2 (3)

 n.s

Urinary

n (%)

2 (18)

17 (25)

 n.s

Catheter

n (%)

1 (1)

 

SSTI

n (%)

3 (4)

 

Unknown

n (%)

2 (3)

 

Bacteriemia

n (%)

0

2 (18)

32 (46)

n.s

Microorganisms

    

MDRa

n (%)

7 (10)

 

Non-MDRb

n (%)

7 (64)

52 (75)

 n.s

Unknown

n (%)

4 (36)

9 (13)

 n.s

Candida spp.

n (%)

1 (2)

 

Organ support and other therapies

    

Antimicrobials within first hour

n (%)

5 (45)

30 (45)

n.s

Corticosteroid therapy

n (%)

1 (11)

2 (18)

29 (42)

n.s

Crystalloids (mL) within first 3 h

1500 (1625)

2000 (1000)

n.s

Vasopressor therapy

n (%)

0

2 (18)

 < 0.001

RRT

n (%)

0

0

15 (22)

n.s

IMV

n (%)

3 (33)

4 (36)

28 (41)

n.s

Analytical data

    

White blood cell count

median (IQR)

13,020 (1030)

18,000 (18,100)

12,140 (15,460)

n.s

CRP (mg/L)

median (IQR)

15 (20)

285 (128)

234 (191)

 < 0.001a

Procalcitonin (ng/mL)

median (IQR)

0.05 (0.08)

2.90 (15.62)

31.80 (93.13)

 < 0.001b

Lactate levels at first hour (mmol/l)

median (IQR)

1.50 (0.55)

2.00 (0.90)

3.85 (4.55)

 < 0.001b

Glucose (mg/dL)

median (IQR)

125 (46)

157 (78)

135 (105)

n.s

Platelet count

median (IQR)

236,000 (91,000)

208,000 (158,000)

147,000 (148,250)

0.002b

Quick index

median (IQR)

91 (24)

73 (17)

61 (31)

 < 0.001b

D-Dimer (ng/ml FEU)

median (IQR)

581 (199)

1121 (1170)

3145 (5684)

0.008b

PT (seconds)

median (IQR)

26 (8)

35 (15)

40 (18)

0.001b

Outcomes

    

ICU LOS (days)

median (IQR)

4 (6)

5 (7)

6 (11)

n.s

Hospital LOS (days)

median (IQR)

21 (15)

10 (10)

16 (25)

n.s

ICU mortality

n (%)

2 (22)

2 (18)

13 (19)

n.s

  1. (−) not available. n.s not significant. Data are expressed as median (IQR) or n (%)
  2. APACHE Acute Physiology and Chronic Health Evaluation; CRP C−reactive protein; ICU Intensive Care Unit; IMV Invasive Mechanical Ventilation; LoS length of stay; PT Prothrombin time; RRT Renal Replacement Therapy; SSTI Skin and Soft Tissue Infection; SOFA Sequential Organ Failure Assessment; MDR multidrug resistant microorganisms, aMDR (extended Spectrum Betalactamase−producing Escherichia coli, MR Pseudomonas aeruginosa and Methicillin Resistant Staphylococcus aureus), bNon−MDR (Escherichia coli, Klebsiella pneumoniae, Enterococcus faecalis, Enterococcus faecium, Enterobacter cloacae, Streptococcus mitis and Streptococcus pneumoniae). LOS length of stay
  3. aControl vs sepsis
  4. bControl vs Septic Shock
  5. csepsis vs septic shock